Clinical Trials
15 trialsNCT02113878 2024-11-05
Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck
Dana-Farber Cancer Institute
Phase 1 Completed
NCT03517488 2022-12-01
DUET-2
Xencor, Inc.
Phase 1 Completed
NCT00006036 2020-04-06
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
Canadian Cancer Trials Group
Phase 1 Completed
NCT00036790 2019-12-17
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
University of Wisconsin, Madison
Phase 1 Completed
NCT00978081 2019-04-23
Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT01800071 2018-07-17
A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma
Cancer Research UK
Phase 1 Completed
NCT00706316 2015-07-10
NPC-CTL
University Health Network, Toronto
Phase 1 Completed
NCT00003430 2013-06-25
L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00101270 2013-06-05
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
National Cancer Institute (NCI)
Phase 1 Completed
NCT00609219 2012-10-10
NPC
Baylor College of Medicine
Phase 1 Completed
NCT00078546 2012-07-30
CLANC
Baylor College of Medicine
Phase 1 Completed
NCT01147991 2012-02-28
Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer
Cancer Research UK
Phase 1 Completed
NCT01256853 2011-12-22
Modified Vaccinia Ankara (MVA) Vaccine Study
Chinese University of Hong Kong
Phase 1 Completed
NCT00002901 2010-01-13
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function
City of Hope Medical Center
Phase 1 Completed
NCT00078494 2008-03-04
Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed